The Core Tradeoff: Scale vs. Context
The debate between outsourced RCM companies and in-house billing teams usually gets framed as a cost question. For denial appeals specifically, cost is the wrong first lens — speed and context are. Appeals are time-sensitive (most payers give 90 to 180 days, some far less) and they're highly dependent on clinical and payer-specific context. Whoever wins the appeal race in 2026 will be whoever solves both.
Outsourced RCM companies bring scale: dedicated denial specialists, established payer relationships, and processes refined across many clients. In-house teams bring context: direct access to providers for medical necessity clarification, institutional knowledge of the practice's own documentation habits, and no hand-off delay between denial and response.
Where RCM Companies Win
RCM companies typically win on volume economics. A firm handling denials across dozens of client practices sees a given payer's denial pattern far more often than any single practice does, which compounds into genuine expertise on what specific payers respond to.
They also tend to have more mature tracking infrastructure — dedicated denial management software, defined escalation paths, and staff whose full-time job is appeals rather than a biller juggling appeals alongside claims submission, payment posting, and patient billing.
Where In-House Teams Win
In-house teams win on speed of clinical clarification. When an appeal needs additional physician documentation or a peer-to-peer call, an in-house team can often get that same day. An outsourced firm has to route the request back to the practice, wait for a response, and then act — and that round-trip delay is exactly what causes missed windows on shorter payer deadlines.
In-house teams also carry more institutional memory about how a specific practice codes, what its EHR templates capture (and don't), and which providers tend to under-document specific service types — context that's expensive for an outside firm to build and maintain.
The Hybrid Model Gaining Ground
Increasingly, the winning model isn't a binary choice — it's an in-house team responsible for triage, provider communication, and final review, paired with an outsourced or software-driven layer that handles the mechanical, repetitive parts of packet assembly. That combination captures the in-house team's speed and context advantage while getting the scale benefits of specialized tooling or partners for the parts of the process that don't require practice-specific judgment.
The practices seeing the best appeal-to-payment rates in 2026 are generally the ones that have stopped treating this as an either/or decision and started treating it as a division of labor: humans (in-house or outsourced) own judgment calls and relationships; structured tools own consistency, speed, and packet assembly.
What This Means for 2026
As payer-side denial automation continues to scale, the appeal race increasingly comes down to turnaround time and consistency, not just appeal quality on any single claim. Groups evaluating whether to build in-house, outsource, or blend the two should weight speed-to-response and process consistency as heavily as cost per appeal — because a well-written appeal filed after the deadline is worth exactly as much as no appeal at all.
ResolveRCM works for both models — as a force multiplier for in-house teams and as the standardized packet-generation layer RCM companies use across every client. Learn more. |